Fig. 5: OECT performances upon three repeated experiments.
From: Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies
Device repeatability tests. OECTs have been employed up to three consecutive times (developing a cleaning procedure between the experiments) to monitor Sars-Cov-2-infected cell lines (red), with non-neutralizing (blue) and neutralizing (magenta) antibodies, together with neutralizing serum control (green). OECT first, second, and third uses are reported in (a)–(c), respectively.
